Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hepatitis b vaccine (recombinant) (Recombivax) (3 trials)
inactivated SARS-Cov-2 vaccine (5 trials)
Digestive System Diseases (Phase 4)
Gastrointestinal Diseases (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Liver Diseases (Phase 4)
Trials (8 total)
Trial APIs (2 total)